We are an International Multi-Organizational Coalition addressing gaps in the prevention, prompt diagnosis and management of AIDS globally.
GAFFI set an ambitious target of ensuring that 95% of the world’s population have access to antifungal agents by 2025. The following agents are on the WHO’s Essential Medicines List: fluconazole, itraconazole, voriconazole, amphotericin B, flucytosine, echinocandins (micafungin, caspofungin, anidulafungin) and natamycin eyedrops. Information about the drugs is available here: https://en.fungaleducation.org/treatments/
Other agencies recognise the important of access to generic antifungals, including GARDP https://revive.gardp.org/lack-of-access-to-generic-antibiotics-and-antifungals-is-an-overlooked-issue-in-amr/
Here GAFFI presents maps showing availability of key antifungal medicines in each country, how many generic varieties there are, as well as minimum and maximum price.
